欧洲统一专利法院判Align胜诉：时代天使Torque Ridges被认定侵权 须在17国停售并召回销毁
San Jose——隐形牙套厂商 Align Technology（纳斯达克：ALGN）10月17日宣布，欧洲统一专利法院（UPC）巴黎地方分院10月16日裁定，时代天使（Angelalign，港交所：6699.HK）带有 Torque Ridges 功能的矫治器系统侵犯 Align 的欧洲专利 EP 2 237 738 B1，该专利对应 Align 的 Power Ridge 技术。
法院驳回了时代天使对专利有效性的挑战，发出禁令要求其召回并销毁侵权产品、向 Align 支付赔偿，并须停止在奥地利、比利时、保加利亚、丹麦、爱沙尼亚、芬兰、法国、德国、意大利、拉脱维亚、立陶宛、卢森堡、马耳他、荷兰、葡萄牙、斯洛文尼亚与瑞典共17个国家提供带 Torque Ridges 的矫治器系统。该裁决仍可上诉。
Align 于2025年8月在包括统一专利法院在内的多个法域对时代天使集团多家公司提起专利侵权诉讼。Align 副总裁兼知识产权与许可副总法律顾问 Arthur S. Hsieh 表示，该裁决是 Align 的重大胜利，彰显保护研发投入成果的重要性；他同时指出，时代天使称其近期已在欧洲停用 Torque Ridges 并推出名为 Pressure Points 的新功能，不应掩盖法院已认定 Torque Ridges 侵权的事实，时代天使已公开表示将遵守裁决。Align 表示尚未就 Pressure Points 是否涉及其知识产权表态，将继续评估相关产品并在必要时采取行动。
这场专利战还有多条战线：2026年2月，统一专利法院曾就 Align 的 ClinCheck Live Update 技术发出初步禁令，后获上诉法院维持，实体审理仍在进行；2026年7月，美国国际贸易委员会（ITC）就 Align 主张的五项专利举行证据听证，预计11月作出初步裁定；2026年8月，济南市中级人民法院一审认定时代天使相关数字化正畸系统侵权，时代天使已提起上诉，Align 表示将在中国继续推进其他侵权诉讼。
Align 总部位于加州 San Jose 与亚利桑那州 Tempe，旗下 Invisalign 隐形矫治系统全球累计治疗患者约2,350万人次。
Align Wins Unified Patent Court Case Against Angelalign: Torque Ridges Found Infringing, Recall Ordered Across 17 Countries
SAN JOSE, Calif. — Align Technology, Inc. (Nasdaq: ALGN) announced on October 17 that the Paris Local Division of the Unified Patent Court (UPC) ruled on October 16 that aligner systems incorporating Angelalign's Torque Ridges feature infringe Align's European Patent EP 2 237 738 B1, which relates to Align's Power Ridge technology.
The court rejected Angelalign's challenges to the patent's validity, issued an injunction requiring the company to recall and destroy infringing products, ordered it to pay damages to Align, and barred it from offering aligner systems with Torque Ridges in 17 countries: Austria, Belgium, Bulgaria, Denmark, Estonia, Finland, France, Germany, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Portugal, Slovenia and Sweden. The decision is subject to appeal.
Align initiated the proceedings in August 2025 against several companies in the Angelalign group (HKEX: 6699.HK) in multiple jurisdictions. Arthur S. Hsieh, Align's vice president and Deputy General Counsel for Intellectual Property & Licensing, called the ruling a significant victory that underscores the importance of protecting the innovations resulting from Align's research and development investment. He noted that Angelalign has said it recently discontinued Torque Ridges in Europe and introduced a different feature called Pressure Points, and that Angelalign has publicly stated it will comply with the ruling. Align said it has not taken a public position on whether Pressure Points implicates its intellectual property and will continue to evaluate products offered by Angelalign and others.
The dispute spans several other fronts. In February 2026, the UPC issued a preliminary injunction over Align's ClinCheck Live Update technology, later upheld by the Court of Appeal, with merits proceedings ongoing. In July 2026, the U.S. International Trade Commission held an evidentiary hearing on five patents asserted by Align, with an initial determination expected in November 2026. In August 2026, the Jinan Intermediate People's Court in China issued a first-instance judgment finding infringement by Angelalign's digital orthodontic systems; Angelalign has appealed, and Align said it is pursuing additional actions in China.
Headquartered in San Jose, California, and Tempe, Arizona, Align's Invisalign system has treated approximately 23.5 million patients worldwide.
发布：GSM·美国（发布链接）
图片来源：Invisalign 透明矫治器特写（Smikey Io 摄，CC BY-SA 3.0，via Wikimedia Commons）
GSM Global · 本篇英文版 English edition of this story
